About us

Company details

CORPORATE OVERVIEW

AmCad BioMed Corporation (AmCad) was founded in 2008 and was listed on Taipei Exchange in the March of 2015 (Ticker: 4188).

AmCad BioMed Corporation is dedicated to developing innovative Computer-Assisted Detection and Diagnosis (CAD) devices. The company has successfully developed and commercialized a series of the pioneering, first-in-the-world medical devices.

AmCad's Blue Ocean Strategy for the CAD systems is to develop its own core-technology platforms by providing high value-added, state-of-the-art medical solutions targeting a wide variety of clinical applications and raising the global competition to a higher level. We are ready to make extensive contribution to the health